Expression of MMPs, MT-MMP, and TIMPs in squamous cell carcinoma of the oral cavity: Correlations with tumor invasion and metastasis

Head and Neck

Volumn 21, Issue 7, 1999, Pages 627-638

  Kurahara, Shin Ichi ^a   Shinohara, Masanori ^a,b   Ikebe, Tetsuro ^a   Nakamura, Seiji ^a   Beppu, Mahiro ^a   Hiraki, Akimitsu ^a   Takeuchi, Hiroshi ^a   Shirasuna, Kanemitsu ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Metastasis; MMP; Squamous cell carcinoma; TIMP

Indexed keywords

COLLAGENASE; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ARTICLE; CANCER INVASION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HUMAN; HUMAN TISSUE; METASTASIS; MOUTH CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TUMOR CELL;

ADULT; AGED; BIOPSY, NEEDLE; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASES; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; METALLOENDOPEPTIDASES; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM INVASIVENESS; PROGNOSIS; SENSITIVITY AND SPECIFICITY; TISSUE INHIBITOR OF METALLOPROTEINASES; TUMOR MARKERS, BIOLOGICAL;

EID: 0032822534     PISSN: 10433074     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0347(199910)21:7<627::AID-HED7>3.0.CO;2-2     Document Type: Article

References (38)

1. Liotta LA, Rao CV, Barsky SH. Tumor invasion and the extracellular matrix. Lab Invest 1983;49:636-649.
2. Carter RL, Burman JF, Barr L. Immunohistochemical localization of basememt membrane type IV collagen in invasive and metastatic squamous cell carcinoma of head and neck. J Pathol 1985;147:159-164.
3. Sark WA, Zarbo RJ, Jacobs JR, Crissman JD. Distribution of basement membrane in squamous cell carcinoma of the head and neck. Hum Pathol 1987;18:1043-1050.
4. Oguro K, Kazama T, Isemura M, Nakamura T, Akai S, Sato Y. Immunohistochemical alterations in basement membrane components of squamous cell carcinoma. J Invest Dermatol 1991;96:250-254.
5. Kumagai S, Kojima S, Imai K, Nakagawa K, Yamamoto E, Kawahara E, Nakanishi I. Immunohistologic distribution of basement membrane in oral squamous cell carcinoma. Head Neck 1994;16:51-57.
6. Harada T, Shinohara M, Nakamura S, Oka M. An immunohistochemical study of the extracellular matrix in oral squamous cell carcinoma and its association with invasive and metastatic potential. Virchow Archiv 1994;424: 257-266.
7. Shinohara M, Nakamura S, Harada T, Shimada M, Oka M. Mode of tumour invasion in oral squamous cell carcinoma: improved gradiing based on immunohistochemical examination of extracellular matrices. Head Neck 1996; 18:153-159.
8. Kusukawa J, Sasaguri Y, Shima I, Kameyama T, Morimatsu M. Expression of matrix metalloproteinase-2 related to lymph node metastasis of oral squamous cell carcinoma. A clinicopathologic study. Am J Clin Pathol 1993; 99:18-23.
9. Shima I, Kusukawa J, Nakano R, Yamana H, Fujita H, Kakegawa T, Morimatsu M. Production of matrix metalloproteinases 9 (92-kDa gelatinase) by human oesophageal squamous cell carcinoma in response to epidermal growth factor. Br J Cancer 1993;67:721-727.
10. Nakagawa H, Yagihshi S. Expression of type IV collagen and its degrading enzymes in squamous cell carcinoma of lung. Jpn J Cancer Res 1994;85:934-938.
11. Matrisian LM, Wright J, Newell K, Witty JP. Matrix-degrading metalloproteinases in tumor progression. Princess Takamatsu Symposia 1994;24:152-161.
12. Kusukawa J, Sasaguri Y, Morimatsu M, Kameyama T. Expression of matrix metalloproteinasse-3 in stage I and II squamous cell carcinoma of the oral cavity. J Oral Maxllofac Surg 1995;53:530-534.
13. Miyajima Y, Nakano R, Morimatsu M. Analysis of expression of matrix metalloproteinases-2 and -9 in hypopharyngeal squamous cell carcinoma by in situ hybridization. Ann Oto Rhinol Laryngol 1995;104:678-684.
14. Tokuraku M, Sato H, Murakami S, Okada Y, Watanabe Y, Seiki M. Activation of the precursor of gelatinase A/72kDa type IV collagenase/MMP-2 in lung carcinoma correlates with the expression of membrane-type matrix metalloproteinase (MT-MMP) and with lymph node metastasis. Int J Cancer 1995;64:355-359.
15. Kawata R, Shinomiya T, Yasuda N, Takenaka H, Murakami Y. Matrix metalloproteinase-2 concentrations in squamous cell carcinoma of the head and neck and its clinical significance. J Oto Rhino Laryngol 1996;99: 299-305.
16. Kusukawa J, Harada H, Shima I, Sasaguri Y, Kameyama T, Morimatsu M. The significance of epithelial growth factor receptor nad matrix metalloproteinase-3 in squamous cell carcinoma of the oral cavity. Europ J Cancer B Oral Oncol 1996;32:217-221.
17. Garzetti GG, Ciavattini A, Lucarini G, Goteri G, Romanini C, Biagini G. The 72-kDa metalloproteinase immunostaining in cervical carcinoma: relationship with lymph nodal involvement. Gynecol Oncol 1996;60:271-276.
18. Kawamata H, Nakashiro K, Uchida D, Harada K, Yoshida H, Sato M. Possible contribution of active MMP-2 to lymph node metastasis and secreted cathepsin-L to bone invasion of newly established human oral squamous cancer cell lines. Int J Cancer 1997;70:120-127.
19. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, Seiki M. A matrix metalloproteinase expressed on the cell surface of invasive tumor cells. Nature 1994;370: 61-64.
20. Ohuchi E, Imai K, Fujii Y, Sato H, Seiki M, Okada Y. Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J Biol Chem 1997;272:2446-2451.
21. Yamamoto E, Kohama G, Sunagawa H, Iwai M, Hiratsuka H. Mode of invasion: bleomycin sensitivity and clinical course in squamous cell carcinoma of oral cavity. Cancer 1983;50:2157-2180.
22. Polette M, Nawrocki B, Gilles C, Sato H, Seiki M, Tournier JM, Birembaut P. MT-MMP expression and localisation in human lung and breast cancers. Virchow Archiv 1996;428:29-35.
23. Tokuraku M, Sato H, Watanabe Y, Seiki M. Expression of membrane-type matrix metalloproteinase (MT-MMP) and activation of MMP-2 in lung cancer. Jpn J Clinic Med 1995;53:1822-1826.
24. Nakahara H, Howard L, Thompson EW, Sato H, Seiki M, Yeh Y, Chen WT. Transmembrane/cytoplasmic domain-mediated membrane type-1 matrix metalloproteinases docking to invadopodia is required for cell invasion. Proc Nat Acad Sci USA 1997;94:7959-7964.
25. Yamamoto M, Mohanam S, Sawaya R, et al. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro. Cancer Res 1996;56:384-392.
26. Fishman DA, Bafetti LM, Stack MS. Membrane-type matrix metaloloproteinase expression and matrix metalloproteinase-2 activation in primary human ovarian epithelial carcinoma cells. Invasion Metastasis 1996;16: 150-159.
27. Okada A, Bellocq JP, Rouyer N, Chenard MP, Rio MC, Chambon P, Basset P. Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stroma cells of human colon, breast and head and neck carcinomas. Proc Nat Acad Sci USA 1995;92:2730-2734.
28. Gilles C, Polette M, Piette J, Munaut C, Thompson EW, Birembaut P, Foidart JM. High level of MT-MMP expression is associated with invasiveness of cervical cancer cells. Int J Cancer 1996;65:209-213.
29. Nomura H, Sato H, Seiki M, Mai M, Okada Y. Expression of membrane-type matrix metalloproteinase in human gastric carcinomas. Cancer Res 1995;55:3263-3266.
30. Tsunezaki Y, Kinoh H, Takino T, Watanabe Y, Okada Y, Shinagawa A, Sato H, Seiki M. Expression of membrane-type matrix metalloproteinase 1 (MT1-MMP) in tumor cells enhances pulmonary metastasis in a expression metastasis assay. Cancer Res 1996;56:5678-5683.
31. Yoshizaki T, Sato H, Maruyama Y, Murono S, Fukukawa M, Park CS, Seiki M. Increased expression of membrane type 1-matrix metalloproteinase in head and neck carcinoma. Cancer 1997;79:139-144.
32. Nawrocki B, Polette M, Marchand V, Maquoi E, Beorchia A, Tournier JM, Foidart JM, Birembaut P. Membrane-type matrix metalloproteinase-1 expression at the site of human placentation. Placenta 1996;17:565-572.
33. Nuova GJ, Macconnell PB, Simsir A, Valea F, French DL. Correlation of the in situ detection of polymerase chain reaction-amplified metalloproteinase complementary DNAs and their inhibitors with prognosis in cervical carcinoma. Cancer Res 1995;55:267-275.
34. Charous SJ, Stricklin GP, Nanney LB, Netterville JL, Burkey BB. Expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases in head and neck squamous cell carcinoma. Ann Otol Rhinol Laryngol 1997; 106:271-278.
35. Strongin AY, Collier I, Bannikov G, Manner BL, Grant GA, Goldberg GI. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J Biol Chem 1995;270;5331-5338.
36. Imai K, Ohuchi E, Aoki T, Nomura H, Fujii Y, Sato H, Seiki M, Okada Y. Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases 2. Cancer Res 1996;56:2707-2710.
37. Ailenberg M, Silverman M. Cellular activation of mesangial gelatinase A by cytochalasin D is accompanied by enhanced mRNA expression of both gelatinase A and its membrane-associated gelatinase A activator (Mt-MMP). Biochem J 1996;313:879-884.
38. Grigioni WF, D'Errico A, Fiorentino M, Baccarini P, Onisto M, Caenazzo C, Stetler-Stevenson WG, Garbisa S, Mancini AM. Gelatinase A (MMP-2) and its mRNA detected in both neoplastic and stromal cells of tumors with different invasive and metastatic properties. Diagnos Molecul Pathol 1994;3:163-169.